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ABSTRACT
Deoxyribonucleoside triphosphates (dNTPs) are vi-
tal for the biosynthesis and repair of DNA. Their
cellular concentration peaks during the S phase of
the cell cycle. In non-proliferating cells, dNTP con-
centrations are low, making their reliable quantifi-
cation from tissue samples of heterogeneous cellu-
lar composition challenging. Partly because of this,
the current knowledge related to the regulation of
and disturbances in cellular dNTP concentrations
derive mostly from cell culture experiments with lit-
tle corroboration at the tissue or organismal level.
Here, we fill the methodological gap by presenting
a simple non-radioactive microplate assay for the
quantification of dNTPs with a minimum require-
ment of 4–12 mg of biopsy material. In contrast to
published assays, this assay is based on long syn-
thetic single-stranded DNA templates (50–200 nu-
cleotides), an inhibitor-resistant high-fidelity DNA
polymerase, and the double-stranded-DNA-binding
EvaGreen dye. The assay quantified reliably less than
50 fmol of each of the four dNTPs and discrimi-
nated well against ribonucleotides. Additionally, ther-
mostable RNAse HII-mediated nicking of the reac-
tion products and a subsequent shift in their melt-
ing temperature allowed near-complete elimination
of the interfering ribonucleotide signal, if present. Im-
portantly, the assay allowed measurement of minute
dNTP concentrations in mouse liver, heart and skele-
tal muscle.
INTRODUCTION
Deoxyribonucleoside triphosphates (dNTPs) are building
blocks of DNA and, accordingly, their cellular concentra-
tion is highest during active DNA synthesis, such as in pro-
liferating cells (1). Basal dNTP levels in non-proliferating
or postmitotic cells are only ∼5% that of in cells in S phase
and are mainly required for DNA repair and maintenance
of mitochondrial DNA (1,2). While studying pyrimidine
biosynthesis in a mouse model of mitochondrial respira-
tory complex III deficiency (3), we encountered the prob-
lem that no suitablemethod, applicable for the general labo-
ratory without special instrumentation, to measure dNTPs
from tissue samples exists. Traditional enzymatic methods
to measure dNTPs have relied on the incorporation of ra-
dioactive dNTPs to a complementary strand of a DNA
template by a DNA polymerase (4,5). These methods have
mainly been used to measure dNTPs from actively prolif-
erating cultured cells with high dNTP concentrations and
a limited complexity of interfering biological matrix. Re-
cently, a HPLC-MS-based method was developed that al-
lows quantification of tissue dNTP levels from a feasibly
small tissue amount (15–30mg) (6). However, not every lab-
oratory has suitableHPLC–MS equipment and expertise. A
simple probe hydrolysis-based enzymatic fluorometric assay
has also been developed to measure dNTPs from cultured
cells (7). This assay utilizes synthetic DNA templates with
a 3′ primer-binding region, mid-template dNTP-detection
region, 5′ probe-binding sequence, and a Taq DNA poly-
merase with 3′ to 5′ exonuclease activity to hydrolyse the
probe - an adaptation of typical TaqMan qPCR chem-
istry. The authors achieved low baseline fluorescence by
using dual-quenched 6-carboxyfluorescein (FAM) -labelled
probes. Due to the simplicity of this fluorometric assay, we
set out to test it as a means to quantify dNTPs in mouse
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liver extracts. We found some limitations in the sensitivity
and robustness of this method, especially concerning com-
plex tissue extracts with low dNTP concentrations. There-
fore, we developed a novel and even simpler assay based on
a long synthetic template, EvaGreenDNAdye, and a robust
inhibitor-resistant high-fidelity DNA polymerase.
MATERIALS AND METHODS
Reagents
Integrated DNA Technologies (IDT) (Coralville, Iowa,
USA) synthetized all DNA oligonucleotides used for the
dNTP measurements (Supplementary Table S1). The IDT
Ultramer technology was applied for the synthesis of the
197 nucleotide (nt) templates which were then desalted. The
primers and the 50-nt templates for the novel assay were
PAGE purified as were the templates for the published (7)
probe-hydrolysis based assay. The probes were HPLC puri-
fied. Supplementary Table S2 lists all critical reagents, ma-
terials and instrumentation of the study.
Cell culture
Mouse hepatoma cells (Hepa1–6), mouse embryonic skin fi-
broblasts (NIH/3T3), human neonatal skin fibroblasts (8),
and monkey fibroblast-like kidney cells (COS-1) were cul-
tured in standard high-glucose medium (DMEM, 10% fe-
tal bovine serum, Glutamax, penicillin and streptomycin).
Human colorectal cancer cells (HCT116)were cultured sim-
ilarly but RPMI1640 containing 25 mMNaHCO3 was used
as a base medium.
For the dNTPs measurements, the cells were plated into
75- or 25-cm2 flasks (ThermoFisher Scientific) and allowed
to reach the logarithmic growth phase. Hepa1–6 cells were
treated with either vehicle or 5 M 5-fluorouracil (from 5
mM stock in H2O) or 200 nM myxothiazol (from 0.5 mM
stock in EtOH) for ∼6 h. For sample collection, the cells
were washed with phosphate-buffered saline (PBS) and de-
tached with TrypLE (ThermoFisher Scientific). Then, 3.5–
10 ml ice-cold PBS was added, an aliquot was saved for
counting of the cells, and the cells were pelleted by centrifu-
gation (300g for 5 min at +4◦C). The cell pellets were re-
suspended in 550 l of ice-cold 60% MeOH and stored at
–80◦C until extraction.
Generation of a Pacific oyster alternative oxidase-expressing
mammalian cell line
Alternative oxidase (AOX) cDNA from Pacific oyster
(Crassostrea gigas) (Genbank, #ACL31211) (9) was cloned
into the pcDNA6A mammalian expression vector (Invitro-
gen). First, an internal EcoRI site was removed by PCRmu-
tagenesis (primers 5′-ATTCGCACCAGCAATGGGCT-
3′ and 5′-ACC ACT GAC CCT CAG TAG AAT T-3′) and
then the coding sequence was PCR-amplified (primers 5′-
ATGAATTC ATGGGAAGT TTGCGACAAATAAC-
3′and 5′-ATCTCGAG TCA CTT CCC TGG CTC ATA
AGG-3′ or 5′-ATCTCGAG CTT CCC TGG CTC ATA
AGG ATT-3′) and cloned into pcDNA6A with or without
a C-terminal V5–6XHis tag. The cDNA was further sub-
cloned into the SleepingBeauty transposon (10) donor plas-
mid ITR\CAG-MCS-IRES-Puro2A-Thy1.1\ITR (a kind
gift fromDrMadis Jakobson, Max Planck Institute of Bio-
chemistry, Germany).
The expression and subcellular localization of the Pa-
cific Oyster AOX (PoAOX) was confirmed by transfect-
ing the pcDNA6-poAOX-V5–6XHis construct into COS-
1 cells, followed by immunofluorescence staining (Sup-
plementary Figure S1A). To visualize mitochondria and
PoAOX, mouse anti-MT-CO1 (ab14705, Abcam) and rab-
bit anti-V5 (AB3792, Merck) antibodies were used, respec-
tively.
To generate a cell line stably expressing PoAOX,Hepa1–6
cells were co-transfected with a plasmid encoding SB100X
transposase and the Sleeping Beauty transposon donor
plasmid carrying the PoAOX-V5–6XHis insert (1:10 ratio)
using FuGENE® HD transfection reagent. For a con-
trol cell line, the empty ITR\CAG-MCS-IRES-Puro2A-
Thy1.1\ITR plasmid was transfected. After puromycin se-
lection (2 g/ml), resistant colonies were pooled, and af-
ter five passages the cells were cultured without puromycin.
The activation and activity of poAOXwas assessed by mea-
suring antimycinA-resistant respiration usingOxygraph-2k
(OROBOROS instruments) (Supplementary Figure S1B).
Collection and homogenization of mouse tissues
Mice of congenic C57BL/6JCrl background were main-
tained in individually ventilated cages at the animal facil-
ities of University of Helsinki, Finland, under the internal
license KEK19–033.Male mice (110–140 days old) were eu-
thanized by cervical dislocation and the tissues were imme-
diately excised and placed in liquid nitrogen and stored at –
80◦C. The frozen tissue samples were directly homogenized
in ice-cold 60% MeOH (20–40 mg/0.55 ml) using battery-
operated microtube pestles for liver and roughened glass-
to-glass tissue grinders for heart and skeletal muscle (whole
calf).
Extraction of dNTPs
The cultured cells and mouse tissue homogenates in 60%
MeOH were further denatured by incubation at 95◦C for 3
min to quench residual enzymatic activity and to facilitate
the extraction. Supernatants (550 l) from an 18500g cen-
trifugation (6 min at +4◦C) were run through 3-kDa cut-
off centrifugal filters (Amicon Ultra-0.5 ml, Merck) into
pre-weighted collection tubes to remove remaining macro-
molecules. Next, MeOH and hydrophobic metabolites were
removed by washing the extracts twice with 1.4 ml diethyl
ether. Residual diethyl ether was evaporated using Speed-
Vac Plus SC110A centrifugal vacuum evaporator (Savant
Instruments, Farmingdale, NY, USA) (typically 15 min at
65◦C). The remaining liquid after evaporation was esti-
mated by weighing the tubes and assuming that 1l weights
1 mg. Supplementary Table S3 lists the extract dilution used
for the different measurements from cultured cells. The tis-
sue extract dilutions are given in the figures, and tables, and
their respective legends. For initial test runs (Supplemen-
tary Figure S2A–D), we also followed a published extrac-
tion protocol without modifications (7). The extracts were
stored at –80◦C until use.
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Probe hydrolysis-based enzymatic assay for dNTPs
For the fluorochrome-quencher-probe -based polymerase
assay for dNTPs, we followed the published protocol (7)
with minor modifications. To accommodate the relatively
higher sample volume and 384-well format, we lowered the
reaction volume from 25 to 10 l and added the reaction
components as a 2×-master mix followed by addition of
an equal volume of sample. The final reaction concentra-
tions were: 0.4 M primers, probes and templates, 100 M
non-limiting dNTPs, 2 mM MgCl2, and AmpliTaq Gold
DNA polymerase at 35 U/ml. The reaction was started
by activating the hot-start polymerase by a 10-minute in-
cubation step at 95◦C. Baseline fluorescence was read at
60◦C immediately after polymerase activation. Thereafter,
the reaction was allowed to proceed at 60◦C while mon-
itoring the fluorescence. The Bio-Rad CFX384 qPCR in-
strument served as a thermal cycler and fluorometer for the
assay.
Q5 DNA polymerase and EvaGreen-based assay for dNTPs
using 197-nt templates
The following reaction concentrations were found to be op-
timal: 1× Q5 reaction buffer: 0.275 M primer and 0.25
M template, 50 M non-limiting dNTPs and 1.25 M
EvaGreen (Biotum). The optimal Q5 DNA polymerase
(New England Biolabs) amount was template-dependent:
20 U/ml for dATP and dTTP, and 10 U/ml for dGTP
and dCTP detection. The reaction components were pre-
pared as a 2×-master mix and 5 l of the mix was pipet-
ted into opaque wells of 384-well PCR-plate (Bio-Rad).
Then an equal volume of sample was added. The reaction
set-up was prepared on ice. For initial optimization runs,
the thermal cycler (CFX384, BioRad) was programmed to
heat the plate to 98◦C (10s) followed by cooling to the final
reaction temperature (66◦C was considered optimal). The
baseline fluorescence was immediately read after reaching
the target temperature. Thereafter, the fluorescence (SYBR
Green/FAM channel of the instrument) was recorded typi-
cally once every 5min for 75min. Later, the assay was found
more sensitive when the baseline and the end-point fluo-
rescence were read at a temperature above the primer an-
nealing temperature (75◦C). With this approach we found
it best to limit the actual reaction time at 66◦C to 55 min for
dATP, 40 min for dTTP and dCTP, and 20 min for dGTP
detection.
Elimination of interfering signal from ribonucleotides
The reaction component concentrations were the same as
for the basic assay, with the exception that the templates
were shortened to 50 nt and 0.2 U/ml thermostable RNAse
HII (IDT) was included in the reaction mixture. The fol-
lowing reaction times at 66◦C were found optimal for the
50-nt templates: 50 min for dATP, 25 min for dTTP and
dCTP, and 15min for dGTP detection. The baseline and the
end-point fluorescence were read above the melting temper-
ature of RNAse HII-nicked DNA as determined according
to melt curve analyses: 75◦C for dATP and dCTP, 78◦C for
dTTP and 73.5◦C for dGTP.
Denaturing gel electrophoresis
The assay reactions of 20 l volume with and without
0.2 U/ml thermostable RNAse HII were stopped by de-
creasing the temperature to 0◦C and by addition of 12
mM EDTA. Then the reactions were dried using Speed-
Vac Plus SC110A centrifugal vacuum evaporator and dis-
solved in 10 l of 8 M urea and 6% Ficoll in TBE (89 mM
Tris-borate, 2 mM EDTA, pH 8.3). After 2 min denatu-
ration at 95◦C and snap-cooling on ice, the samples were
resolved in pre-heated 13% polyacrylamide 8 M urea–TBE
gels. The single-stranded DNAs (ssDNAs) were visualized
with PAGE GelRed stain (Biotium). Modifications for the
post-reaction alkaline cleavage of ribonucleotide bonds are
explained in the supplementary figure legends.
Data analysis
To export the raw fluorescence values for data analysis,
the automatic baseline correction by the qPCR instrument
was turned off. Nonlinear least squares regression curves
were calculated using GraphPad Prism 8.2.1 (GraphPad
Software, CA, USA). Signal-to-noise ratio was defined as
background-subtracted fluorescence (n = 3) divided by the
standard deviation of the background (n = 6). The lowest
limit of quantification (LLOQ) was estimated as the low-
est concentration at which 33% differences could still be re-
liably distinguished. At this concentration signal-to-noise
ratio was equal to or higher than 10. The measured con-
centrations were corrected for losses during 3 kDa cut-off
filtration. This was accomplished by weighing the residual
liquid in the filter device and assuming a 0.92 g/ml density
of 60% MeOH at 0◦C.
Step-by-step protocol
A detailed step-by-step protocol for sample extraction and
measurement procedure is provided as a Supplementary file.
RESULTS
Design of the assay concept
We initially tested the published probe hydrolysis-based en-
zymatic assay (7) for the measurement of hepatic dNTPs.
However, we encountered two problems. First, the sug-
gested AmpliTaq Gold DNA polymerase appeared to be
sensitive to inhibition by liver, heart and skeletal muscle
extracts, as shown by signal below background level (Fig-
ure 1 and Supplementary Figure S2A–E). To dissect the
cause of the problem, we employed cultured cancer cells
(HCT116) with much higher dNTP concentrations. Dilute
extracts fromHCT116 cells did not cause as obvious inhibi-
tion, but still we were only able to measure the most abun-
dant dNTP, dTTP, without a trouble (Supplementary Fig-
ure S2E). Concentrating the cell extracts for the measure-
ment of the less abundant dNTPs resulted in interference
similar to the tissue extracts (Supplementary Figure S2F–
H). Secondly, we observed a time-dependent increase in the
background fluorescence, which greatly limited the sensi-
tivity of the probe-based assay (Figure 1A, Supplementary
Figure S2). We reasoned that the increasing background
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Figure 1. Long synthetic DNA oligonucleotides, an inhibitor-resistant high-fidelity DNA polymerase and EvaGreen detection chemistry allow quantifi-
cation of dNTPs from mouse liver extracts. (A) A representative quantification of dTTP using a published fluorometric probe-hydrolysis-based assay. For
clarity, curves from three lowest standard samples (0.31–0.08 pmol) are not shown. (B) A representative quantification of dTTP using Q5DNApolymerase,
197-nt template and EvaGreen detection chemistry. (C, D) dTTP signal generated by the fluorometric methods from a high concentration mouse liver ex-
tract with and without 0.5 pmol dTTP spike-in calibrant. The extract volume was adjusted to 2l per mg of initial tissue weight. The extract comprised half
of the reaction. (E, F) Standard curves generated from the end-point baseline-corrected fluorescence values. The lowest y-axis value shows the background
signal. Gray lines present the 95% confidence interval of a polynomial curve fit.
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fluorescence could originate from the low-fidelity nature of
the non-proofreading polymerase leading to eventual incor-
poration of a wrong (non-complementary) deoxyribonucle-
tide in the presence of the highly unbalanced dNTP con-
centrations required by the assay. Given that no commer-
cially available true high-fidelity polymerase with 5′ to 3′
exonuclease activity required for probe hydrolysis exists, we
replaced the fluorochrome- and quencher-labelled probes
with theEvaGreen double-strandedDNA (dsDNA) dye, in-
creased the template length to 197 nt, and performed the as-
say with an inhibitor-resistant high-fidelity Q5 DNA poly-
merase (Figures 1B, D and 2). The designed template DNA
oligomers had the same primer-binding and a single dNTP-
detection site at the 3′end as in the original probe-based
assay (Supplementary Table S1). The EvaGreen-based de-
tection system produced an increasing fluorescence sig-
nal, which was proportional to the added limiting dNTP
(Figure 1B). Importantly, the background fluorescence re-
mained nearly constant during the whole reaction time, and
the highly concentrated liver extracts spiked with known
amounts of dNTPs also produced the expected increase in
signal (Figure 1D).
To test our hypothesis that the error rate of the DNA
polymerase could be a major determinant of the assay
background, we performed the assay with EvaGreen de-
tection using a typical Taq polymerase (AmpliTaq Gold),
Phire DNA polymerase (2× fidelity versus Taq), Phusion
polymerase (52× fidelity versus Taq) and Q5 polymerase
(280× fidelity versus Taq). Indeed, the DNA polymerase
with the highest rated fidelity produced the lowest back-
ground (Figure 3A). However, using the EvaGreen de-
tection chemistry, the non-proofreading AmpliTaq Gold
DNA polymerase also gave a rather stable background
in comparison to the probe-based assay, suggesting that
unspecific probe hydrolysis could also play a role in the
probe-based detection. The novel EvaGreen-based assay
also worked with Phire and Phusion DNA polymerases
without any prior optimization (Figure 3A, B). The Phire
DNA polymerase showed somewhat faster reaction kinet-
ics than the other three enzymes. Based on the lowest back-
ground signal, and reported (11) inhibitor resistance in
DNA extraction-free PCR, we chose to continue the opti-
mization with Q5 DNA polymerase.
Optimization of the reaction conditions
We systematically optimized the concentration of key reac-
tion components and temperature to maximize sensitivity
and to decrease the cost of the assay (Figure 4). A decrease
in primer and template concentration from 0.4 to 0.2Mal-
most halved the background, without notable reduction in
specific signal, for inputs <2.5 pmol (Figure 4A). A slight
excess of primer (1.25-fold) over the template marginally
improved the assay at the reaction temperature of 68◦C
(Supplementary Figure S3A). Non-limiting dNTP concen-
trations between 25 and 100 M had little effect on the as-
say performance (Figure 4B).We chose the concentration of
50 M as optimal for later runs The EvaGreen concentra-
tion recommended by the manufacturer for qPCR proved
to be optimal (Figure 4C and Supplementary Figure S3B).
The DNA polymerase concentration of 20 U/ml was re-
quired for the optimal quantification of dATP, whereas 10
U/ml was sufficient for dGTP quantification (Figure 4E-
F). The polymerase concentration of 20 U/ml marginally
improved the performance of dTTP and dCTP quantifi-
cation in comparison to 10 U/ml (Supplementary Figure
S3C-D). We varied the reaction temperature between 64
and 72◦C and found that optima lied between 66 and 68◦C
(Figure 4D). Lower temperatures increased the background
and higher ones compromised the assay. Because annealed
primers bind EvaGreen (12), we also tested whether we
could improve the signal-to-noise ratio by reading the base-
line and the end-point fluorescence above the melting tem-
perature of the primer extended to the detection site. In-
deed, this approach increased the signal-to-noise ratio by
approximately 3-fold (Figure 4G).
After all optimization, we found that the assay produced
a linear response for inputs of 20–250 fmol (Figure 5). Sig-
moidal curve fits, however, described the standard curves
overall more accurately and gave a dynamic quantitative
range up to 2 pmol (Figure 5I–L). We empirically verified
the LLOQdown to 30 fmol for dATP, dTTP and dCTP. The
detection of dGTP showed a slightly higher background,
and therefore LLOQ of 47 fmol. The assay was the most
sensitive for dATP and based on the signal-to-noise ratio of
10 as low as 9 fmol would be quantifiable. We also found
that instead of baseline-subtracted end-point fluorescence,
the standard curve could also be generated from end-point
DNAmelting temperature data by using the rate of fluores-
cence change at a specific temperature as a dependent vari-
able (Supplementary Figure S4). This resulted in a further
increase in signal-to-noise ratios.
As the high sensitivity of 197-nt templates is not required
for all samples, we also tested the assay using 50-nt tem-
plates (Figure 6). As expected, the shorter templates de-
creased the fluorescence values and a large part of the sig-
nal came from the primer when the fluorescence was mon-
itored during the reaction phase (Figure 6A–D). However,
recording both the baseline and end-point fluorescence at
a temperature above the primer annealing temperature di-
minished the primer-related signal. This allowed a usable
quantitative range of 90 fmol to 2 pmol for all four dNTPs
with the 50-nt templates (Figure 6E–L).
Assessment of interference by ribonucleoside triphosphates
(rNTPs)
Cellular rNTP concentrations are several dozen- to
thousand-fold higher than the corresponding dNTPs, and
mostDNApolymerases canmisincorporate rNTPs to some
degree (13). Therefore, we estimated rNTP-to-dNTP ra-
tios that could occur in cultured cells and post-mitotic tis-
sues (5,14,15). Then, we tested how well our assay dis-
criminates against purified commercially available rNTPs
at such ratios (Figure 7). Adding purified rNTPs to the
reactions to achieve typical rNTP-to-dNTP ratios present
in cultured cells did not cause marked interference in the
dNTP signals (Figure 7A–D). However, the much higher
rNTP-to-dNTP ratios putatively present in post-mitotic tis-
sue samples caused a clear increase in dATP and dGTP sig-
nals. Because commercial molecular biology-grade rNTP
preparations derive from biological sources (generally of
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Figure 2. The principle of the novel dNTP assay. Single-stranded DNA templates comprise a 3′ primer-binding site followed by a single detection site for
the dNTP to be quantified (here dGTP). The rest of the template, in the 5′ direction, does not contain any cytosines, and its sole purpose is to maximize the
amount of double-stranded DNA synthesized per a single dGTP incorporated by the DNA polymerase. The double-stranded DNA binds the EvaGreen
fluorochrome and renders it fluorescent, which is measured. In this method, the template length determines the signal amplification.
98–99% purity), and may therefore contain trace amounts
(∼0.015%) of dNTPs, it was essential to verify whether
the observed rNTP interference was real or due to a small
amount of contaminating dNTP in the rNTP preparations
(added in huge excess to achieve the biologically relevant
ratios). The constant excess of the rNTP, but gradual ex-
haustion of the corresponding dNTP, during the reaction
should lead to a time-dependent increase in the interfering
signal. This was indeed the case when we assessed dGTP
in the presence of 1000-fold excess GTP, implying true in-
terference (Figure 7E). However, this did not occur when
we assessed dATP in the presence of 5000-fold excess ATP,
suggesting that the interfering signal was not due to ATP
incorporation (Figure 7F). To verify this, we utilized the
50-nt templates and performed the reactions in the pres-
ence of thermostable RNAse HII and subjected the prod-
ucts to melt curve and denaturing gel electrophoresis anal-
yses.When the product strand contains a ribonucleotide op-
posite to the detections site, RNAse HII induces a nick that
will cause lowering of the product melting temperature. In-
deed, RNAse HII caused a clear shift in DNAmelting tem-
perature in the case of dGTP-detection reactions contain-
ing 0.5 mM GTP (Figure 7G). This shift did not occur in
the dATP-detection reactions containing even 2 mM ATP
(Figure 7H), indicating that ATP was not significantly in-
corporated. As a more traditional means of assessing rNTP
incorporation, we also analysed the reaction products using
denaturing gel electrophoresis. In this analysis, the cleav-
age of the ribonucleotide bond opposite to the detection
site by RNAse HII is detectable as a 33-nt band when the
50-nt assay templates are used. The ribonucleotide bond-
indicating cleavage product was clearly visible in the reac-
tions containing 1000-fold excess GTP with Q5 and two
other processivity-enhanced DNA polymerases (Phire and
Phusion). Interestingly, a Taq polymerase seemed to incor-
porate GTP at a lower rate. In contrast, ATP incorpora-
tion by Q5 and the three other DNA polymerases were be-
yond the detection limit of 0.1 ng ssDNA (∼12 fmol of 33-
nt cleavage product, Supplementary Figure S5) (Figure 7J).
As a positive control for rNTP incorporation, a Thermo-
coccus 9◦N-7mutant (D141A/E143A/A485L) DNA-RNA
polymerase (available commercially as Therminator poly-
merase from New England Biolabs) readily incorporated
ATP and gave a prominent cleavage product, which con-
firmed that the RNAse HII did cut this particular ribonu-
cleotide bond. We also repeated the experiment with alka-
line cleavage of ribonucleotide bonds with similar results
(Supplementary Figure S6). In summary, only GTP caused
a significant interference in the corresponding dNTP signal
with Q5 polymerase.
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Figure 3. Assay kinetics with four different DNA polymerases. (A) Time-dependent increase in baseline-corrected fluorescence in the presence of different
concentrations of limiting dNTP (dCTP). (B) Standard curves with second-order polynomial curve fit generated from end-point fluorescence values (1 h).
Gray lines present the 95% confidence interval of the curve fit. Y-axis starts from the background signal. The same primer (0.4 M), template (0.4 M),
non-limiting dNTP (100 M) and EvaGreen (1×) concentrations were used for all reactions and in buffers supplied by the manufacturers of the DNA
polymerases. Reaction temperatures were 60◦C for AmpliTaq Gold (17.5 U/ml), 61.7◦C for Phire (20 l/ml) and Phusion (10 U/ml), and 68◦C for Q5 (10
U/ml). The reaction temperature for Phire, Phusion and Q5 were chosen based on recommendations by the manufacturer. In the case of AmpliTaq Gold,
the reaction temperature was selected based on the published probe-hydrolysis based assay.
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Figure 4. Optimization of EvaGreen- and Q5 DNA polymerase-based dNTP quantification. (A–F) Each critical reaction component and reaction tem-
perature was varied, and the outcome evaluated. (G) The end-point fluorescence was measured at 66◦C and after raising the temperature to 75◦C to
dissociate unused primers. (H) Assay conditions in graphs A to G. The standard curves were generated from the end-point baseline-corrected fluorescence
values. The assessments were performed in triplicates. Supplementary Figure S3B shows the effect of increasing EvaGreen concentration above 1.25 M.
Supplementary Figure S3C-D shows the effect of different DNA polymerase concentrations on the dTTP and dCTP quantification.
Elimination of rNTP interference by RNAse HII and ribonu-
cleotide bond-specific shift in DNA melting temperature
We realized that the high specificity of EvaGreen for ds-
DNA allows the elimination of interfering rNTP signal by
means of nicking the ribonucleotide bonds with a ther-
mostable RNAse HII followed by reading the end-point
fluorescence at a temperature at which the nicked DNA is
denatured but the intact products remain double stranded
(Figure 8A). We tested this approach with the 50-nt tem-
plates with which the cleavage of the ribonucleotide bond
theoretically causes a 5–9◦C decrease in the DNA melting
temperature. The inclusion of thermostable RNAse HII in
the reactionmixture and reading the end-point fluorescence
between 73.5 and 76◦C essentially abolished the interfering
GTP signal (Figure 8B).We also utilized the same approach
to reassess the increase in dNTP signal in the presence of ex-
cess UTP and CTP, two rNTPs with which the apparent in-
terference was much slighter in comparison to GTP (Figure
8C).
Optimization of sample preparation
As the starting point, we chose the widely used 60%
methanol extraction (5–7,16,17). We also adopted a brief
heat denaturation (5,7,16) and a 3-kDa cut-off centrifugal
filtration (7) from previous studies to remove residual enzy-
matic activity-related interference (18) and any remaining
macromolecules that could increase baseline fluorescence,
and produce unspecificDNApolymerisation or polymerase
inhibition. For enzymatic assays, themethanol extracts have
typically been evaporated to dryness in vacuum. To mini-
mize nucleotide hydrolysis, oxidation and deamination re-
actions, we chose a more rapid approach and extracted the
methanol with diethyl ether. Similar diethyl ether washing
steps have been validated for the extraction of several dif-
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Figure 5. Assay performance with the 197-nt templates after optimization. (A–D) Time-dependent increase in baseline-subtracted fluorescence during the
reaction phase of the assay. The baseline fluorescence was read at 75◦C before progression to the primer annealing at 66◦C and initiation of the reaction
phase. (E–L) Standard curves generated from the end-point fluorescence values read after the increase of temperature to 75◦C, a temperature at which the
partially extended primers (17 nt) dissociate from templates. (E–G) Linear regression standard curves for the assay at low range. The dotted line shows
signal-to-noise ratios of 10 as a reference to approximate the lowest limit of quantification. (I–L) Least-squares sigmoidal curve fits for the full range of
the assay. The standard samples were assessed in triplicates and the background (0 pmol) in sextuplicates. The variation coefficients of replicates generally
ranged from 1 to 6% and therefore error bars as standard deviation or standard error of mean are not show for clarity as they would not have been separable
from the data point symbols. The left y-axis in the standard curve figures starts from the background value.
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Figure 6. Assay performance with the 50-nt templates. (A–D) Time-dependent increase in baseline-subtracted fluorescence during the reaction phase of
the assay. (E–L) Standard curves generated from the end-point fluorescence values measured at indicated temperatures (left y-axis title). (E–G) Linear
regression standard curves for the assay at low range. The dotted line shows signal-to-noise ratios of 10 as a reference to approximate the lowest limit of
quantification. (I–L) Least-squares sigmoidal curve fits for the full range of the assay. The standard samples were assessed in triplicates and the background
(0 pmol) in sextuplicates. The variation coefficients of replicates generally ranged from 1 to 5% and therefore error bars as standard deviation or standard
error of mean are not show for clarity as they would not have been separable from the data point symbols. The left y-axis in the standard curve figures
starts from the background value.
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Figure 7. Assessment of interference by rNTPs. (A–D) The assay reactions (197-nt templates) were spiked with the indicated amounts of rNTPs and
the change in the dNTP signal was measured. The concentrations shown are final reaction concentrations. The estimated upper ranges for rNTP/dNTP
ratios are shown for cultured cell and post-mitotic tissues. (E, F) The effect of reaction time on the apparent interfering GTP (E) and ATP (F) signal.
The purple dashed line represents the expected increase in the interfering signal assuming true ATP incorporation, essentially steady-state supply of
ATP, and a time-dependent exhaustion of dATP during the reaction. Reaction time-independent increase in signal suggests trace amounts (∼0.015%) of
dATP in the ATP preparation. (G, H) Melt curve analysis of RNAse HII-nicked 50-nt products of rGTP/dGTP (G) and rATP/dATP assay reactions
(H). For reactions containing 2 mM ATP, 1.6 mM MgCl2 was added to compensate the chelation of Mg2+ by ATP. (I, J) Denaturing polyacrylamide
(13%) gel electrophoresis of the reaction products with and without thermostable RNAse HII. The rNTP-incorporating Thermococcus 9◦N-7 mutant
DNA polymerase (Therminator) was used as positive control for the ATP incorporation. Supplementary Figure S6 shows similar assessment of ATP
incorporation using alkaline cleavage of ribonucleotide bonds. The error bars in the figures represent standard deviation and mean from three technical
replicates.
ferent nucleotides (19). The residual diethyl ether was easily
removed by boiling the sample tubes cap open for 1 min or
by a short evaporation (∼15 min) in a vacuum centrifugal
evaporator at 65◦C. The diethyl ether extraction step pre-
sumably also removes some putative non-polar DNA poly-
merase inhibitors such as hemin, bilirubin and bile acids
based on the solubility of these compounds.
Determination of dNTP concentrations in cultured cells
As a biological validation of the novelmethod, wemeasured
dNTP levels from a mouse hepatoma cell line (Hepa1–6)
cultured with or without 5 M 5-fluorouracil, a thymidy-
late synthase inhibitor that blocks dTTP biosynthesis (Ta-
ble 1). After a 6-hour treatment, 5-fluorouracil had depleted
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Figure 8. Utilization of thermostable RNAse HII and differential DNA melting temperature to eliminate interfering rNTP signal. (A) Schematic presen-
tation of an assay modification to remove interfering rNTP signal. (B) Temperature-dependent decrease in interfering GTP signal in reactions containing
0.2 U/ml thermostable RNAse HII. Shaded grey area illustrates the optimal temperature range for the recoding of end-point fluorescence. (C) Apparent
increase in dNTP signal in the presence of excess rNTP when the rNTP elimination modification was used. The bar graphs represent mean and standard
deviation from three replicates.
dTTP levels to one fifth of the levels in untreated cells. 5-
fluorouracil also decreased dGTP and dCTP concentration
to some extent, while that of dATP was increased. Sev-
eral other cancer cells lines have shown similar pattern of
changes in response to 5-fluorouracil (7,20). We also tested
the effect of inhibition of pyrimidine biosynthesis by block-
ing mitochondrial respiratory complex III with 200 nM
myxothiazol for 6 h. Complex III is required for the ac-
tivity of dihydroorotate dehydrogenase (DHODH), a mito-
chondrial inner-membrane quinone oxidoreductase needed
for the de novo biosynthesis of pyrimidine nucleotides (21).
Myxothiazol decreased the levels of all dNTPs (Table 1),
suggesting it halted cell proliferation as previously shown
for lymphoblastic Jurkat T-cell line (22). This was depen-
dent on complex III because the myxothiazol-induced de-
cline in dNTPs was prevented by the expression of Pacific
oyster alternative oxidase (PoAOX), an enzyme that can by-
pass the blockade of the complex III-IV segment of the
respiratory electron transfer (Supplementary Figure S1B),
as also previously shown by its heterologous expression in
yeast (9).
Determination of dNTP concentrations in mouse tissues
To demonstrate the true utility of our method, we mea-
sured dNTP concentrations in mouse liver, heart and skele-
tal muscle, tissues comprising mostly non-dividing cells
and therefore having minimal dNTP concentrations. Our
method was easily able to quantify all four dNTPs from
these three tissues either with the 197-nt (Supplementary
Table S4) or 50-nt templates (Table 2). With the 50-nt tem-
plates, we utilized the RNAse HII-based modification to re-
move putative rNTP-interference. The results were largely
similar with andwithout thismodification, except for dGTP
in the heart, for which the rNTP-interference removal mod-
ification resulted in lower values (–46%, –4.5 SDs). We as-
sessed the biological sample-related DNA polymerase inhi-
bition by spiking the reactions with 0.25 pmol dNTPs and
found that the detection efficiencies ranged from 90 to 100%
(Supplementary Table S5). We also tested different extract
dilutions and found only minimal inhibition (Supplemen-
tary Figure S7). Supplementary Figures S8–S10 show rep-
resentative fluorescence values during the reaction phase, at
endpoint, and also the melt curve analyses of the reaction
products.
Across the four tissues, dATP was the least abundant
dNTP (∼0.2 pmol/mg tissue) while dTTP and dGTP con-
centrations were at least 2-fold higher (Table 2). Heart tissue
showed the most asymmetric dNTP pools with dGTP con-
centration approximately 2 pmol/mg while the concentra-
tions of other dNTPs were more similar to that in the liver
and skeletal muscle.
dNTP pool asymmetry in different samples and comparison
to previously reported values
To obtain data comparable to previous studies (5,7,15), we
measured dNTP concentrations in cultured human carci-
noma cells (HCT116), mouse fibroblasts (NIH/3T3) and in
primary human fibroblasts (Table 1).We compared the pub-
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Table 1. dNTP concentrations in cultured cells, pmol/106 cells
Cell line Treatment/condition Transgene dTTP dATP dCTP dGTP
Mouse hepatoma (Hepa 1–6) Untreated 42 ± 6.9 15 ± 2.3 133 ± 25 4.7 ± 0.8
5 M 5-fluorouracil 7.8 ± 0.9 24 ± 0.9 67 ± 7.2 1.4 ± 0.1
Vehicle (0.008% EtOH) empty vector 40 ± 2.5 18 ± 2.4 161 ± 13 7.5 ± 0.5
200 nM myxothiazol empty vector 3.8 ± 0.6 4.6 ± 1.5 3.5 ± 0.5 0.5 ± 0.4
200 nM myxothiazol PoAOX 43 ± 4.4 23 ± 3.8 163 ± 30 13 ± 3.8
Human colorectal carcinoma
(HCT116)
n/a 16.7 ± 2.4 8.2 ± 0.9 5.3 ± 0.8 2.8 ± 0.5
Human neonatal skin
fibroblasts
n/a 23 ± 2.8 10.8 ± 0.9 12.3 ± 0.8 4.9 ± 0.1
Mouse embryonic skin
fibroblasts (NIH/3T3)
n/a 31.4 ± 2.1 8.1 ± 0.9 15 ± 1.6 4.7 ± 0.5
The values represent mean± SD from three distinct cell culture flasks. The treatment time for 5-fluorouracil and myxothiazol was 6 h. The extract dilutions
are shown in Supplementary Table S3. The 197-nt templates were used for these measurements.
Table 2. dNTP concentrations in mouse tissues, pmol/mg tissue
dTTP dATP dCTP dGTP Extract dilution [volume per initial tissue weight]
Liver 0.87 ± 0.22 0.20 ± 0.03 0.39 ± 0.08 0.51 ± 0.08 6 l/mg
Heart 0.64 ± 0.17 0.20 ± 0.01 0.24 ± 0.04 2.3 ± 0.25 6 l/mg: dTTP, dATP, dCTP 20 l/mg: dGTP
Skeletal muscle 0.58 ± 0.13 0.16 ± 0.02 0.11 ± 0.04 0.46 ± 0.1 5 l/mg
The values represent mean ± SD from four independent biological replicates. The dNTP concentrations were measured using the 50-nt templates and the
rNTP-interference elimination step. The extract dilutions refers to the dilution before the assay.
lished data to our results (Table 3). In cultured mammalian
cells, dTTP has been reported to comprise nearly 50% of
the total dNTP pool, while dGTP has usually been the least
abundant dNTP.We also found this pattern in the colorectal
carcinoma cell line HCT116, and in culturedmouse and hu-
man fibroblasts. The mouse hepatoma cell line (Hepa1–6)
showed a somewhat different pattern, with the dCTP com-
prising most of the dNTPs.
We obtained HPLC-MS-quantified reference data for
mouse heart and skeletal muscle from the studies by Olaf-
sson et al. (6) and Tran et al. (23). Despite deviation
in the absolute values, this reference data and our data
showed highly similar dNTP pool asymmetry patterns for
the mouse heart (Table 3). In this tissue, dGTP comprised
∼70% of the dNTP pool. In the mouse skeletal muscle, the
dNTP pool was more symmetric according to our results
and the published data.
In summary, apart from the inevitable variation that
likely arises from the slightly different cell culture condi-
tions, cell batches, extraction procedures and mouse strains
in different laboratories, we found an excellent agreement
between our and published results on dNTP levels across
different sample types.
DISCUSSION
Balanced dNTP pools are vital for efficient error-free DNA
synthesis (1). The current knowledge related to regulation
and fluctuations in dNTP pools derive mainly from cell cul-
ture experiments. Tissue dNTP pools in health and disease
have been studied surprisingly little. This has likely been
partly because of the low concentrations of dNTPs in tissue
samples and the lack of a sensitive-enoughmethodology. To
fill this methodological gap, we developed a simple robust
method able to quantify each of the four canonical dNTP
from mouse tissue biopsies.
Our novel and the published enzymatic fluorometric as-
say (7) share a number of benefits over the traditional
methods based on radionucleotide incorporation. First, the
quantification reaction takes place in a single microplate
well and requires only pipetting of a reagent mix and
the sample. Secondly, a typical qPCR instrument can be
used for the temperature control and to read the fluo-
rescence. Whereas in the case of radionucleotide-based
detection, the reaction products have to be transferred
onto filter paper, washed multiple times, and quantified
using a scintillator. Such manual labour-requiring steps
are prone to human error and limit the feasible number
of samples that can be analysed simultaneously. In ad-
dition, handling of radioactive reagents requires permits
and stringent safety measures. Recently, an improved en-
zymatic radionucleotide-based assay for dNTPs was devel-
oped in which biotinylated oligonucleotide templates are in-
corporated onto streptavidin-coated microplates to facili-
tate washing steps and recovery of the synthetized radio-
labelled DNA (17). The inventors of this assay measured
dNTPs from several cell lines, but they did not report suit-
ability of the assay for tissue samples.
A novel innovation of our method is the utilization of
the highly sensitive EvaGreen detection chemistry for ds-
DNA, and recent advances in chemical oligonucleotide syn-
thesis that allow production of ultralong (∼200 nt) ss-
DNA templates at reasonable cost. EvaGreen is a well-
characterized intercalating DNA fluorochrome that shows
higher specificity for double-stranded versus ssDNA than
the more traditional SYBR Green fluorochrome used in
qPCR (12). Moreover, it can be used at saturating concen-
tration without DNA polymerase inhibition. The fluores-
cence of EvaGreen is proportional to the molar concen-
tration and length of dsDNA, and therefore the template
length determines the signal amplification in our method.
We found the maximum sensitivity with the ultralong 197-
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Table 3. dNTP pool sizes in various samples and comparison to previously published values
Sample
dTTP %
(pmol/106
cells or
pmol/mg)
dATP %
(pmol/106
cells or
pmol/mg)
dCTP %
(pmol/106
cells or
pmol/mg)
dGTP %
(pmol/106
cells or
pmol/mg) Reference Method
Mouse hepatoma cell line
(Hepa 1–6)
22% (42) 7.5% (15) 68% (133) 2.4% (4.7) This study
Human neonatal skin
fibroblasts
45% (23) 21% (11) 24% (12) 10% (4.9) This study
Human skin fibroblasts 47% (92) 22% (47) 21% (44) 9% (18) Ferraro et al. 2010 (5) Enzymatic
and HPLC
Mouse skin fibroblasts
(NIH/3T3)
53% (31) 14% (8.1) 25% (15) 8% (4.7) This study
Mouse skin fibroblasts
(BALB/3T3)
41% (92) 20% (44) 31% (70) 8% (18) Kong et al. 2018 (15) HPLC-MS
Human colorectal carcinoma
cell line (HCT116)
51% (17) 25% (8.2) 16% (5.3) 8% (2.8) This study
41% (20) 28% (14) 21% (11) 10% (4.7) Wilson et al. 2011 (7) Enzymatic
Mouse liver 44% (0.87) 10% (0.2) 20% (0.39) 26% (0.51) This study
Mouse heart 19% (0.64) 6% (0.2) 7% (0.24) 68% (2.3) This study
14% (0.2) 2% (0.02) 9% (0.13) 75% (1.0) Olafsson et al. 2017 (6) HPLC-MS
21% 5% 7% 68% Tran et al. 2019 (23) HPLC-MS
Mouse skeletal muscle 44% (0.58) 12% (0.16) 8% (0.11) 35% (0.46) This study
34% (0.34) 18% (0.18) 23% (0.23) 26% (0.26) Olafsson et al. 2017 (6) HPLC-MS
15% (0.15) 33% (0.25) 20% (0.15) 32% (0.23) Ylikallio et al. 2010 (31) Enzymatic
The %-values represent individual dNTP levels normalized to total dNTP concentration. Absolute values (where applicable) are given in the brackets as
pmol/106 cells for cultured cells and as pmol/mg tissue for tissues.
nt templates but even with the 50-nt templates the assay
has sufficient sensitivity for most sample types. One ben-
efit of EvaGreen-based detection as compared to fluores-
cent probes is that the choice of DNA polymerase is not
limited to enzymes possessing 5′ to 3′ exonuclease activity
to hydrolyse the probe. An appropriate DNA polymerase is
crucial for the accurate quantification of dNTPs by the en-
zymatic method. For instance, the commonly used Klenow
fragment can substitute the ribonucleosides GTP and CTP
for the corresponding dNTPs to be quantified (5,24,25). We
found that the Q5 DNA polymerase, which we mainly used
in this work, retains specificity in the presence of rNTP-to-
dNTP ratios typically present in cultured cells. However,
we found this DNA polymerase capable of incorporating
GTP at rates that may bias measurement to some degree
from post-mitotic tissue samples. To overcome this, we took
advantage of EvaGreen’s high specificity for dsDNA and
employed a thermostable RNAse HII to induce a shift in
DNA melting temperature in the products containing a ri-
bonucleotide bond. Due to the template design and given
that the non-limiting dNTPs are provided in large excess,
the interference from rNTPs is essentially limited to a sin-
gle misincorporation at the detection site. Therefore, after
the cleavage of the ribonucleotide bond by RNAse HII, the
specific signal can be separated by reading the fluorescence
at a temperature at which the specific full-length products
remain dsDNA but the unspecific products denature to ss-
DNA. For even more stringent specificity, it is also possi-
ble to perform melt curve analysis and use the rate of fluo-
rescence change at the specific temperature as a readout. A
downside of the rNTP interference removal protocol is that
the maximum template length is limited to approximately
70 nt which decreases the sensitivity to some degree. How-
ever, even with 50-nt templates we found more than suffi-
cient sensitivity to assess dNTPs in tissue extracts. In addi-
tion to theGTP interference, we found an apparent increase
in dATP signal in the presence of 5000–10 000-fold excess
ATP.Measuring dATP in the presence of such high excess of
ATP is, however, problematic as even as low as 0.015% con-
taminating dATP in the ATP preparations would explain
the apparent increase in signal. Therefore, we investigated
this apparent interference by several means, but we did not
find any signs of significant ATP incorporation by the tested
DNA polymerases.
In addition to the discrimination against rNTPs, the
DNA polymerase of choice has to be able to tolerate a
considerable amount of inhibitory impurities, especially in
the case of concentrated tissue extracts. To our knowledge,
the utility of modern inhibitor-resistant high-fidelity DNA
polymerases in the enzymatic determination of dNTPs has
not been investigated before, even though the enzyme in-
hibition is a potential source of error and the DNA poly-
merase fidelity may affect considerably the background sig-
nal.We found that the previous (7) fluorometric assay based
on probes and AmpliTaq DNA polymerase was highly sen-
sitive to inhibition by concentrated tissue and cell extracts
that posed no problem for the processivity-enhanced Q5
DNA polymerase and the EvaGreen detection chemistry.
During the revision of this manuscript Szabo et al. reported
similar problems with the original fluorometric assay and
found unspecific probe hydrolysis as the source of unstable
background (26).Moreover, they identified differential inhi-
bition of exonuclease and polymerase activity of Taq DNA
polymerases by biological samples as the major source of
the interference. They proposed a mathematical correction
for the problem, but we did not have the opportunity test it
for this study.
The highly unbalanced dNTPs required by the enzymatic
methods may lead to eventual incorporation of wrong de-
oxyribonucleotides with a concomitant elevation of back-
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ground signal. We, indeed, found that the DNA poly-
merase with the highest rated fidelity gave the lowest back-
ground. In fact, in the absence of the dNTP to be quanti-
fied no full-length products were visible in melt curve anal-
yses of dATP and dTTP detection reactions with the Q5
DNA polymerase. In the case of dGTP detection reactions
the background-related full-length products were detectable
suggesting a slightly higher error-rate by the enzyme or
traces of dGTP in the detection reagents. However, the poly-
merase error-rate was clearly not the sole factor determin-
ing the background. In fact, we found that the EvaGreen-
based quantification robustly worked with four different
DNA polymerases without any prior optimization. The as-
say was also robust with respect to modest alterations in
the reaction conditions such as temperature, template con-
centration and length, and enzyme amount. Importantly,
after optimization, we verified reliable quantification down
to 30 fmol using 197-nt templates and 90 fmol using 50-
nt templates. In fact, the true LLOQ values are likely to be
lower than these are, especially, if the product melting tem-
perature profile is employed for the calculation of the end-
point readout. As a comparison, a radionucleotide-based
method has been reported to reach a 100 fmol quantifica-
tion limit (data not shown and criteria for LLOQ not re-
ported) (5). Themost sensitive publishedHPLC-MS system
has a LLOQ of 60 fmol, and typically the LLOQ values for
chromatographic methods range from 0.25 to 10 pmol (6).
The previous fluorometric assay based on double-quenched
probes had LLOQ values ranging from 0.8 to 1.3 pmol (7).
Later, the same authors published an addendum describ-
ing a triple-quencher approach that decreases the LLOQ to
0.1 pmol for dTTP. Less stringent criteria (signal-to-noise
ratio of 5) for LLOQ was, however, used by these authors
than by us. Recent findings have also questioned the ro-
bustness of the probe-based detection with biological sam-
ples (26). Recently, a rather elaborate enzymatic two-stage
dNTP detection involving a fluorescent probe, two DNA
fragments, two different DNA polymerases and a DNA lig-
ase was developed (27). This assay could reach a detection
limit that is orders of magnitude lower than any other ex-
isting method could. However, this complex assay was de-
veloped for single-molecule DNA sequencing and its utility
remain undemonstrated with biological samples.
The main reason we set out to develop a new method
was the need to quantify minute dNTP concentrations
from reasonably small mouse tissue biopsies. The first en-
zymatic assay for dNTPs was published 1969 (28). Since
then, small improvements to increase sensitivity and speci-
ficity have been reported (4,5,17,29). All these studies have,
however, included only cultured cells as a biological sam-
ple. Yet, enzymatic methods have been used to measure
dNTP concentrations from liver (30) and skeletal muscle
samples (31–33), but no method validation data for tissue
samples have been reported in these studies. In skeletal mus-
cle samples, individual dNTP concentrations have ranged
from less than 0.02 to 0.3 pmol/mg with the biggest vari-
ation seen in dATP levels (31,32). Interestingly, a HPLC-
MS-based method has also shown surprisingly low dATP
concentrations for mouse heart tissue (0.02 pmol/mg) (6).
Although the ribonucleotide ATP is the physiological sub-
strate for cellular ATPases, several of these enzymes can use
dATP instead of ATP (34,35). We speculate that the varia-
tion in dATP levels could be related to ischemia during sam-
ple collection and delayed quenching of enzymatic activity.
Similar to two chromatographic quantifications (6,23), we
found heart dGTP concentration to be several-fold higher
than that of other three dNTPs.Mitochondrial dNTP pools
are extremely asymmetric with dGTP concentration being
more than 10-fold higher than the concentration of other
dNTPs (16). This asymmetry was reported to be especially
notable in heart mitochondria (155-fold excess dGTP) (16).
Therefore, it is obvious that in mitochondria-rich tissues
such as in heart, dGTP would be the most abundant dNTP.
In summary, according to our results and the published lit-
erature the tissue dNTP concentrations are generally low;
only a fraction of a picomole per mg of tissue.
We acknowledge the following points as room for further
development of the assay. We chose the methanol-based
extraction because of its wide use in previous studies (5–
7,16,17). However, to our knowledge, no systematic com-
parison of different extraction procedures for dNTPs exists
in the literature. We optimized the key parameters of the
dNTP assay for Q5 DNA polymerase. However, this partic-
ularDNApolymerase is not a requirement for the assay and
other DNA polymerases may also be used with minimal ad-
justments. We mainly optimized the assay for maximal sen-
sitivity at low inputs. If necessary, the dynamic range could
be adjusted by varying the number of detection sites in the
template, as done for the probe-based assay (7), or using a
higher template concentration. Interference from dUTP is
an unlikely source of error for most sample types because of
the high cellular dTTP-to-dUTP ratios (36–40).However, in
the case of potential dUTP accumulation e.g. due to the in-
hibition of dUTP catabolism or thymidylate synthesis, the
extracts can be digested with dUTPase to remove the po-
tential interference (7,40,41). In theory, it is also possible
to quantify dUTP by measuring extracts with and without
UTPase digestion and using a readily dUTP-incorporating
DNA polymerase. As with all enzymatic dNTP assays, en-
zyme inhibition and rNTP misincorporation are potential
sources of error. Extended reaction times may mitigate the
enzyme inhibition but increase the probability of rNTP in-
corporation. If necessary, the simple modification to elim-
inate rNTP interference, as presented here, should be em-
ployed. The assay produces a non-linear standard curve at
high input. Thus, if inhibition is present, the StandardAddi-
tion Method is valid only after a careful titration of appro-
priate sample input. Some samples may show intrinsic fluo-
rescence. Therefore, we recommend subtraction of baseline
fluorescence from the end-point fluorescence values. This
correction also decreasedwell-to-well variation.An approx-
imate cost of our assay, excluding sample preparation, is 34
EUR (37USD) per 100 detection reactionswith 197-nt tem-
plates.
In summary, we developed an enzymatic fluorometric as-
say that is simple, inexpensive, and most importantly has
the sensitivity and robustness to measure dNTPs from non-
proliferating cells or from tissue extracts. Without technical
replicates, less than 4 mg tissue or 0.1 × 106 cultured cells is
sufficient. Moreover, 96 and 384-well formats of the assay
allow a large number of samples to be measured simulta-
neously. Only a handful of studies have addressed the topic
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of tissue dNTP levels in health and disease (6,30–32). As
nucleotide metabolism is increasingly studied in the field of
cancer biology and in relation to metabolic diseases such as
mitochondrial disorders (32,42) the availability of an easily
applicable dNTP assay for use in the general laboratory is
of the utmost importance.
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